focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Share Trade and Share Buy-Back

27 Jan 2020 16:08

RNS Number : 0518B
Honeycomb Investment Trust PLC
27 January 2020
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

27 January 2020

Honeycomb Investment Trust plc("Honeycomb" or the "Company")

Proposed Share Trade and Share Buy-Back

Honeycomb announces that it has been informed that in response to substantial investor demand, certain major shareholders of the Company have indicated an intention to sell a significant percentage of the Company's issued ordinary shares of 1 penny each ("Ordinary Shares") at a price of 850 pence per Ordinary Share.

The Company also announces that a major shareholder has irrevocably undertaken to the Company and Pollen Street Capital Limited (the "Investment Manager"), the Company's investment manager, that, for a period of four weeks following this announcement, it will not sell any of its Ordinary Shares in the Company except at a price no lower than 850p per Ordinary Share when instructed to do so by the Company or the Investment Manager.  

In addition, the Company announces that the board has authorised an on-market buyback by the Company of up to 2.2 million Ordinary Shares pursuant to the authority granted at Honeycomb's annual general meeting on 6 June 2019 (the "Buyback"). Liberum Capital Limited ("Liberum") has been appointed to effect the Buyback on the Company's behalf.

The Company has 39,449,919 Ordinary Shares in issue and admitted to trading on the Specialist Fund Segment of the London Stock Exchange with no Ordinary Shares held in treasury. Ordinary Shares purchased by the Company pursuant to the Buyback will be held in treasury.

Shareholders should be aware that a purchase of Ordinary Shares by the Company on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares and could exceed 25 per cent. of the average daily trading volume of the preceding 20 business days.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Liberum Capital Limited - Broker

Chris Clarke / Louis Davies: +44 (0)20 3100 2000

Camarco - Investor Relations

Ed Gascoigne-Pees: +44 (0)20 3757 4994

Link Company Matters Limited - Corporate Secretary

Paula O'Reilly: +44 (0)20 7954 9796

Pollen Street Capital - Investment Manager

Chris Palmer / Steve Plowman: +44 (0)20 3728 6750

This announcement and the information contained herein is for information purposes only and does not constitute or form part of any offer or an invitation to acquire or dispose of securities in the United States, Australia, Canada, Japan or South Africa or in any other jurisdiction in which such an offer or invitation is unlawful ("Restricted Jurisdictions"). Neither this announcement nor any copy of it may be taken, transmitted or distributed, directly or indirectly, in or into or from any Restricted Jurisdiction. Any failure to comply with this restriction may constitute a violation of securities laws in the relevant Restricted Jurisdiction.

In connection with any sale or purchase of Ordinary Shares pursuant to the proposed transactions described in this announcement (the "Sale"), Liberum or any of their respective affiliates may take up a portion of the Ordinary Shares as a principal position and in that capacity may retain, purchase, sell, offer to sell for its own accounts such Ordinary Shares and other securities of the Company or related investments in connection with the Sale or otherwise. Accordingly, references to the Ordinary Shares being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by Liberum and any of their respective affiliates acting as investors for their own accounts. Liberum does not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

Liberum is authorised and regulated by the FCA. This announcement has been issued by the Company and is the sole responsibility of the Company. Liberum does not accept any responsibility whatsoever and makes no representation or warranty, express or implied, for the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by the Company or on Liberum's behalf, in connection with the Sale, and nothing in this announcement is or shall be relied upon as a promise or representation in this respect, whether as to the past or the future. Liberum accordingly disclaims to the fullest extent permitted by law all and any responsibility and liability, whether arising in tort, contract or otherwise, which it might otherwise have in respect of this announcement and any such statement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKFXAEKEEFA
Date   Source Headline
1st Nov 20213:58 pmRNSDirector Declaration
28th Oct 202110:42 amRNSNAV and Monthly Update August 2021 - Replacement
28th Oct 20217:00 amRNSNAV and Monthly Update September 2021
20th Oct 202111:57 amRNSHolding(s) in Company
1st Oct 20217:05 amRNSDirector Declaration
29th Sep 20217:00 amRNSNAV and Monthly Update September 2021
15th Sep 20217:00 amRNSHalf-year Report
8th Sep 20214:53 pmRNSNotification of Board Committee Changes
8th Sep 20217:00 amRNSDividend Declaration
7th Sep 20217:00 amRNSNAV and Monthly Update - July 2021
28th Jul 20217:00 amRNSNAV and Monthly Update - June 2021
29th Jun 20217:00 amRNSNAV and Monthly Update - May 2021
8th Jun 20215:15 pmRNSResult of AGM
28th May 20219:39 amRNSDirector/PDMR Shareholding
27th May 20217:00 amRNSNAV and Monthly Update - April 2021
14th May 202111:54 amRNSDirector/PDMR Shareholding
10th May 20214:53 pmRNSPosting of Annual Report and Notice of AGM
30th Apr 20217:02 amRNSAnnual Report and Audited Financial Statements
30th Apr 20217:01 amRNSDividend Declaration
30th Apr 20217:00 amRNSNAV and Monthly Update - March 2021
1st Apr 20217:00 amRNSNAV and Monthly Update - February 2021
4th Mar 20217:00 amRNSNAV and Monthly Update - January 2021
26th Feb 20217:00 amRNSDividend Declaration
25th Feb 20214:14 pmRNSBoard Committee Changes & SID Appointment
12th Feb 20217:00 amRNSNAV and Monthly Update - December 2020
12th Jan 20211:43 pmRNSHolding(s) in Company
12th Jan 20211:40 pmRNSHolding(s) in Company
12th Jan 202111:38 amRNSHolding(s) in Company
7th Jan 20217:00 amRNSNAV and Monthly Update - November 2020
29th Dec 202012:22 pmRNSDirectorate Change
18th Dec 202010:21 amRNSKepler Trust Intelligence: New Research
1st Dec 20207:01 amRNSMonthly Update – October 2020
1st Dec 20207:00 amRNSNet Asset Value(s)
20th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
19th Nov 20207:00 amRNSDividend Declaration
19th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
18th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
16th Nov 20204:54 pmRNSHolding(s) in Company
13th Nov 202011:11 amRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
12th Nov 20209:50 amRNSHolding(s) in Company
12th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
11th Nov 20207:00 amRNSShare Buy-Back Programme
6th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
4th Nov 20207:01 amRNSMonthly Update - September 2020
4th Nov 20207:00 amRNSNet Asset Value(s)
4th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
3rd Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
2nd Nov 20205:01 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.